OVARIAN ENDOMETRIOID CARCINOMA
Clinical trials for OVARIAN ENDOMETRIOID CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OVARIAN ENDOMETRIOID CARCINOMA trials appear
Sign up with your email to follow new studies for OVARIAN ENDOMETRIOID CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common breast cancer drug keep ovarian cancer at bay?
Disease control Recruiting nowThis Phase 3 trial is testing whether adding letrozole (a hormone-blocking drug) to standard maintenance therapy can delay cancer recurrence in people with estrogen-receptor-positive ovarian cancer. About 540 participants who have completed initial surgery and chemotherapy will r…
Matched conditions: OVARIAN ENDOMETRIOID CARCINOMA
Phase: PHASE3 • Sponsor: Swiss GO Trial Group • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Could a custom tumor map guide better ovarian cancer care?
Knowledge-focused Recruiting nowThis Swiss study is testing whether creating a detailed molecular profile of each patient's tumor can help doctors choose more effective treatments for advanced ovarian cancer. Sixty newly diagnosed patients will be randomly assigned to either standard care or a personalized trea…
Matched conditions: OVARIAN ENDOMETRIOID CARCINOMA
Phase: NA • Sponsor: Swiss GO Trial Group • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:29 UTC